SEEGENE
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark 2022-04-06 20:08
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary 2022-03-17 20:00
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 2022-03-02 20:00
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era 2022-02-24 20:00
Seegene Announces Q4 and Full-Year 2021 Financial Results 2022-02-17 20:00
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil 2022-02-10 20:00
Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing 2022-01-19 20:00
Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests 2022-01-17 20:00
Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order 2022-01-17 20:00
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-13 04:00
Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane 2021-12-29 19:00
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube 2021-12-09 20:18
Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant 2021-11-30 19:25
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum 2021-11-23 16:03
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing 2021-11-15 19:00
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing 2021-10-27 23:40
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC 2021-09-27 19:02
Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests 2021-09-01 17:40
Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY 2021-08-18 18:00
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus 2021-07-13 20:00
1 2 3 4